Pfizer to seek approval for RSV vaccine for people as young as 18
Related Articles
-
Pfizer to seek approval for RSV vaccine for people as young as 18
An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said.
-
Capitals' Ovechkin becomes first player to record 30 goals in 18 seasons
Scoring his 30th goal of the season against the Detroit Red Wings, Ovechkin became the first player in league history to score at least 30 goals in 18 seasons.
-
Republicans who support childhood vaccine mandates often stay silent, research suggests
Most Republican voters support childhood vaccine mandates, yet may be discouraged from publicly expressing these views, a new study suggests.